Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/5B043A0ADC2638732AA96928F8214A47B72259DCD11F1915D7E74C9C3FF619AD2BD6BD95F044DA94CF0EF8A7031794D0http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5B043A0ADC2638732AA96928F8214A47B72259DCD11F1915D7E74C9C3FF619AD2BD6BD95F044DA94CF0EF8A7031794D0http://www.w3.org/2000/01/rdf-schema#comment"Study in metastatic breast cancer patients treated with a taxane-bevacizumab combination chemotherapy revealed that overall and progression-free survival was significantly shorter in patients with a high baseline Tie1 level demonstrating the prognostic value of baseline Tie1 plasma concentration in patients with metastatic breast cancer."xsd:string
http://purl.uniprot.org/uniprot/#_90AF45D1EE27528D09D861CB74F072DD2EC5B0783E51BE4E546869DE14B4F25A95BFC925340666AA14BCE8D07E4FACB2http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/5B043A0ADC2638732AA96928F8214A47B72259DCD11F1915D7E74C9C3FF619AD2BD6BD95F044DA94CF0EF8A7031794D0
http://purl.uniprot.org/uniprot/B5A952http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/5B043A0ADC2638732AA96928F8214A47B72259DCD11F1915D7E74C9C3FF619AD2BD6BD95F044DA94CF0EF8A7031794D0
http://purl.uniprot.org/uniprot/#_B5A952-mappedCitation-31340773http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/5B043A0ADC2638732AA96928F8214A47B72259DCD11F1915D7E74C9C3FF619AD2BD6BD95F044DA94CF0EF8A7031794D0